Eosinophilic pleural effusion associated with the addition of sodium valproate.
Fernández-Pérez
Ramón
R
Alvarez-Dobaño
José Manuel
JM
Suárez-Antelo
Juan
J
Codesido-Barcala
Rosario
R
Carballal-Calvo
Fernando
F
Arrojo-Romero
Manuel
M
de Leon
Jose
J
D018692:Antimanic Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010996:Pleural Effusion / Q000139:chemically induced*; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D014635:Valproic Acid; D003024:Clozapine